Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

13 results
Display

Journal of Obesity & Metabolic Syndrome: A New International Journal Targeting the Pathophysiology and Treatment of Obesity and Metabolic Syndrome

Lim S

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sleep and Obesity in Childhood

Lee JE

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Letter to the Editor: Obesity Markers as Predictors for Colorectal Neoplasia (J Obes Metab Syndr 2017;26:28-35)

Kim JY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Response: Obesity Markers as Predictors for Colorectal Neoplasia (J Obes Metab Syndr 2017;26:28-35)

Kwon JH, Ko HJ, Youn CH, Choi HI

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevalence and Associated Characteristics of Metabolically Healthy Obese Phenotypes in a Community Dwelling Population

Shin S, Kim JM, Sung S, Kim HS

BACKGROUND: Recent research has focused on overweight and obese individuals with healthy metabolic profiles. Metabolically healthy and obese (MHO) individuals may have unique characteristics, compared to metabolically unhealthy obese (MUO)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Metabolic Syndrome is Associated with Lower Plasma Levels of Desacyl Ghrelin and Total Ghrelin in Asymptomatic Middle-aged Korean Men

Cho YH, Lee SY, Jeong DW, Cho AR, Jeon JS, Kim YJ, Lee JG, Yi YH, Tak YJ, Hwang HR, Lee SH, Lee SM

BACKGROUND: Desacyl ghrelin is acylated by ghrelin O-acyltransferase (GOAT) and converted to acyl ghrelin. To date, little is known about the relationship among the levels of these two forms of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Revisional Bariatric Surgery: Focus on Quality of Life

Chew CA, Shabbir A

Bariatric surgery is considered to be the most effective treatment for morbid obesity. At present, revisional surgery is considered in patients who experience complications, or in whom the intended weight...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease

Miura K, Ishioka M, Iijima K

Obesity is characterized by low-grade chronic inflammation and is closely associated with the cardiovascular diseases, diabetes, and nonalcoholic fatty liver disease. Emerging data demonstrate that the gut microbiota contributes to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Does Weight Gain Associated with Thiazolidinedione Use Negatively Affect Cardiometabolic Health?

Ko KD, Kim KK, Lee KR

Thiazolidinediones (TZDs) are oral anti-diabetic drugs that are peroxisome proliferator-activated receptor gamma (PPARγ) agonists and act as insulin sensitizers. The clinical efficacy and durability of the currently available TZDs in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Fulminant Type 1 Diabetes in a Patient with Type 2 Diabetes Mellitus

Kim JM, Han JH, Joung KH, Lee JH, Kim HJ, Ku BJ

Fulminant type 1 diabetes mellitus is a recently identified subtype of type 1 diabetes characterized by abrupt disease onset, a very short (
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development and Cross-Validation of Equation for Estimating Percent Body Fat of Korean Adults According to Body Mass Index

Sung H, Mun J

BACKGROUND: Using BMI as an independent variable is the easiest way to estimate percent body fat. Thus far, few studies have investigated the development and cross-validation of an equation for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Agreement Between Actual and Perceived Body Weight in Adolescents and Their Weight Control Behaviors

Shin SM

BACKGROUND: To investigate the agreements between actual and perceived body weight status among adolescents and to identify the associations of disagreements with their weight control behaviors. METHODS: This study used the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Body Weight Reduction on the SGLT2 Inhibitor in People with Type 2 Diabetes Mellitus

Cho HA, Jung YL, Lee YH, Lee YC, Lee JE, Lee SJ, Jeong SJ, Kim CH

BACKGROUND: Dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, reduces hyperglycemia and body weight by inhibiting renal glucose reabsorption. However, only a few studies have demonstrated efficacy of dapagliflozin for type 2 diabetic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr